Control of Nosocomial Methicillin-Resistant Staphylococcus aureus Infection
To the Editor-We write to express agreement with the statement of Klevens et al. [1] that, "regardless of which [methicillin-resistant Staphylococcus aureus (MRSA)] strains are present in hospitals, action is necessary to control further spread" (p. 391). We believe, however, that their next sentence, "Aggressive programs in several European countries have documented the success of identifying and treating colonized patients quickly," (p. 391) misled readers by implying that health care facilities in those countries (and in Western Australia, which has had similar success with a similar approach [2] ) quickly treat-but do not isolatecolonized patients, and that treating colonized patients is the key secret to those countries' success in controlling MRSA infection. On the contrary, Dutch eradication therapy is often postponed until conditions are optimal (frequently after discharge), whereas isolation is used for all patients with known or suspected MRSA colonization [3] . A recent Dutch study illustrated the importance of isolation, reporting that MRSA was transmitted to 38 individuals when 3 MRSA-colonized patients were admitted to an intensive care unit (ICU) unsuspected, uncultured, and unisolated, compared with transmission to only 1 individual when 3 other patients were suspected, cultures were performed, and the patients were isolated at admission to the same ICU [4] . Successes at the University of Virginia (Charlottesville) over 26 years, as well as at other American hospitals, confirm the importance of identi-fying and isolating all colonized patients [5] [6] [7] [8] , including many situations where eradication therapy was not used [5, [8] [9] [10] [1] , where standard precautions have been required since 1996 (including mandatory annual infectioncontrol retraining of all health care workers). In 1983, the CDC began recommending that contact isolation of patients with known or suspected colonization or infection be used to control spread of epidemiologically important antibiotic-resistant pathogens like MRSA. Data were already available at that time that suggested that success would require active surveillance cultures to identify and isolate all MRSA-colonized patients [5] .
Eradication therapy to eliminate MRSA colonization can help control the spread of infection, because an individual who is no longer a carrier is no longer a reservoir for spread [3, 19, 20] ; however, the very high MRSA prevalence in many US health care facilities would make it difficult to use eradication therapy for primary control of infection (i.e., for logistical reasons, and because of the potentiation of mupirocin resistance). Because active detection and isolation of all colonized patients results in major reductions in rates of infection, even in hospitals with very high levels of endemicity and without the use of eradication therapy [5, 9, 10] , this practice should remain as the mainstay [21] . After MRSA prevalence falls, eradication therapy could then be added judiciously, making its use safe and convenient. [3] . A total of 1564 patients (60%) had signs of rash among evaluable cases. Age-adjusted risks for meningitis (OR, 0.7; 95% CI, 0.6-0.9), encephalitis (OR, 0.5; 95% CI, 0.3-0.6), and death (OR, 0.3; 95% CI, 0.1-0.8) were also similarly decreased in patients with reported rash [4] .
A characteristic rash typically appears transiently in a diffuse maculopapular pattern at the height of febrile symptoms [4] [5] [6] . Few studies have examined the histopathological characteristics of rash lesions in WNV infection. In 1 case series, skin biopsy revealed superficial perivascular lymphocytic infiltrates seen commonly in viral exanthems [6] . Whether the development of rash in WNV infection reflects a functional immunoprotective response to circulating viral antigens requires further investigation and validation. Future surveillance activities should include prospective studies assessing features of rash that might account for its apparent favorable effect against severe disease and mortality in WNV disease.
